Further Information:

Diabetic peripheral neuropathy is one of the most common complications of diabetes, potentially leading to loss of sensation, foot ulcerations and eventually amputation.

Treatment of these complications can be expensive yet many are avoidable, making early identification and intervention key to improving patient outcomes and reducing health costs.

Neuropen^® is the only peripheral neuropathy screening device incorporating both pressure and sharpness tests, giving clinicians a simple, compact solution for testing large and small nerve fibres in the foot.

Peripheral neuropathy cannot be excluded without regular foot screening in conjunction with symptomatic and clinical assessments.

Neuropen^® is an effective aid to this screening programme, meeting and exceeding current practices by being the first dual–purpose, pocket–sized device designed to provide a safe and reliable test.

How Neuropen^® works:

The Neuropen^® is a reusable device that can deliver:
• A 10 g pressure test using Neuropen^® Monofilaments to assess any reduction in sensation in the tested area.
• A 40 g sharpness test using Neurotips single–use neurological examination pins to assess reduced sensation to sharpness or pain in small nerve fibres.